Previous trials such asCOURAGE,ISCHAEMIAandORBITA-1raised the possibility that the benefit of PCI observed in stable angina might be primarily a placebo effect [4,16]. The widely anticipated, placebo-controlled
Ventricular arrhythmias are an important cause of morbidity and mortality and come in a variety of forms, from single premature ventricular complexes to sustained ventricular tachycardia and fibrillation. Rapid developments have taken place over the past decade in our understanding of these arrhythmias and...
Adv Ther (2024) 41:2606–2634 https://doi.org/10.1007/s12325-024-02877-y REVIEW Advances in Clinical Cardiology 2023: A Summary of Key Clinical Trials Patrick Savage · Brian Cox · Michael Shahmohammadi · Bronagh Kelly · Ian Menown Received: March 13, 2024 ...